VISTAPHARM FDA Approval ANDA 213000

ANDA 213000

VISTAPHARM

FDA Drug Application

Application #213000

Documents

Letter2019-12-03

Application Sponsors

ANDA 213000VISTAPHARM

Marketing Status

Prescription001

Application Products

001ELIXIR;ORAL0.05MG/ML0DIGOXINDIGOXIN

FDA Submissions

UNKNOWN; ORIG1AP2019-10-04STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAA

CDER Filings

VISTAPHARM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213000
            [companyName] => VISTAPHARM
            [docInserts] => ["",""]
            [products] => [{"drugName":"DIGOXIN","activeIngredients":"DIGOXIN","strength":"0.05MG\/ML","dosageForm":"ELIXIR;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/04\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/213000Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-10-04
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.